BSECompany UpdateResults27 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Pursuant to Regualtion 47 of SEBI(LODR) Regulations, 2015 we ahereby enclosed News Papar Cliping of our 40 th AGM Ads given in the Paper on 27-08-2026. Kindly take the same ....
Colinz Laboratories Ltd has announced the notice of its 40th Annual General Meeting (AGM) through video conference, book closure, and e-voting. The meeting will be held on September 27, 2026, and the register of members and share transfer books will remain closed from September 15 to 22, 2026.
BSEOthersResults20 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....
Colinz Laboratories Ltd has announced its 40th Annual Report for FY 2025-26, along with the reappointment of directors and other business resolutions.
BSECorp. ActionResults20 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
AS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book from 15-09-2026 to 22-09-2026 for the purpose ....
Colinz Laboratories Ltd has announced the closure of its book from September 15, 2026, to September 22, 2026, for the purpose of its 40th Annual General Meeting (AGM). The company will provide a facility for its members to cast their votes through remote e-voting starting from September 19, 2026, to September 21, 2026. The cut-off date for determining the list of shareholders who may cast their votes electronically is September 15, 2026.
BSEAGM/EGMMgmt Change20 Aug 2026
Colinz Laboratories Ltd
As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....
Colinz Laboratories Ltd has announced the notice of its 40th Annual General Meeting (AGM) and book closure, where the company will consider and adopt the audited financial statements for the financial year ended March 31, 2026, and re-appoint Mr. N. K. Menon as a Director and Whole-Time Director & Chief Executive Officer, and consider the re-appointment of Mr. Menon on terms and conditions.
BSECompany UpdateFundraise12 Aug 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories ....
Colinz Laboratories Ltd has received an open offer from Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 26% of the company's voting share capital for ₹3,53,68,164.
BSECompany UpdateFundraise6 Aug 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 6,54,966 shares, representing 26% of the company's voting share capital, at ₹54 per share.
BSECompany UpdateRelated Party5 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and ....
Colinz Laboratories Ltd has announced an open offer by Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 6,54,966 equity shares of the company at Rs. 54 per share, representing 26.7% of the voting share capital, under the SEBI (SAST) Regulations, 2011.
BSECompany UpdateFundraise31 Jul 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 26% of the company's voting share capital for ₹ 54 per share.
BSECompany UpdateResults31 Jul 2026
Colinz Laboratories Ltd
Dear Sir,
As required under SEBI(LODR), Regulation, 2015, we are submitting herewith the News Paper Publication , published on 31-7-2026 for the Quarter Ended 30-6-2026. Kindly take ....
Colinz Laboratories Ltd has submitted its audited financial results for the quarter ended June 30, 2026, as required under SEBI (LODR) Regulation, 2015. The results show revenue from operations of Rs. 136.26 crore, net profit of Rs. 290.12 crore, and earnings per share of Rs. 9.53.
BSEResultResults30 Jul 2026
Colinz Laboratories Ltd
Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.
Colinz Laboratories Ltd held its board meeting on July 30, 2026, and approved several items, including unaudited financial results for the quarter ended June 30, 2026, director's report, management discussion report, corporate governance report, and the appointment of new directors and auditors.
BSEBoard MeetingResults30 Jul 2026
Colinz Laboratories Ltd
1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) ....
Colinz Laboratories Ltd's board meeting outcome: approved un-audited financial results for Q2 2026, appointed new director, approved management discussion report, corporate governance report, and other documents, and finalized 40th AGM date and mode.